Patient preferences regarding treatment options for Waldenstrom's macroglobulinemia: A discrete choice experiment.

ABSTRACT:

Introduction

Treatment options for Waldenström's Macroglobulinemia (WM) have expanded rapidly in the last decades. However, there is no consensus on a preferred treatment. Therefore, patient preferences become increasingly important in making individualized treatment plans. Still, WM patients' priorities and perspectives regarding their treatment options are unknown. We evaluated treatment preferences of WM patients using a discrete choice experiment (DCE).

Methods

A mixed-method approach was utilized for identification and selection of attributes/levels. The DCE questionnaire included five attributes: type of agent (targeted versus chemotherapy); frequency and route of administration; 5-year progression-free survival (PFS); adverse events; and risk of secondary malignancies

SUBMITTER: Amaador K 

PROVIDER: S-EPMC9939214 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature